Jazz Pharmaceuticals unit launches private offering of $1 billion exchangeable senior notes due 2032 - JAZZ News | RalliesJazz Pharmaceuticals unit launches private offering of $1 billion exchangeable senior notes due 2032
J
JAZZ• Concurrent share repurchase plan
- Jazz Pharmaceuticals also plans to repurchase up to $225 million of ordinary shares from note buyers using cash on hand.
Private offering of exchangeable senior notes
- Jazz Pharmaceuticals announced a private offering of $1 billion exchangeable senior notes due 2032.
- Initial purchasers get a 13-day option to buy up to an additional $150 million of the notes.
- Net proceeds are earmarked for general corporate purposes.
BILL
•
